SCHEMBL4438686

SCHEMBL4438686

N#CCc1ccccc1Sc1ccccc1CC#N.O=C(O)Cc1ccccc1Sc1ccccc1CC(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP12 P39900 1/20 0.48
AKR1B1 P15121 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
FFAR1 O14842 2/20 0.41
FFAR4 Q5NUL3 1/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
RECQL P46063 1/20 0.40
CXCL8 P10145 3/20 0.40
ALDH1A1 P00352 1/20 0.39
RXRA P19793 1/20 0.38
RXRB P28702 1/20 0.38
RXRG P48443 1/20 0.38
PTGS2 P35354 2/20 0.38
AKR1B10 O60218 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438683 0.86 CYP2C9 (0.69) HPGDCYP2C9CYP2C19MMP2MMP9
SCHEMBL4437147 0.84 ALDH1A1 (0.46) HPGDCYP2C9CYP2C19LMNAALDH1A1
SCHEMBL6935255 0.83 AKR1B1 (0.55) HPGDMMP2MMP9MMP12AKR1B1
Hydrochloric Acid SCHEMBL4556353 0.82 ALDH1A1 (0.44) HPGDCYP2C9CYP2C19LMNASMN1; SMN2
SCHEMBL3765157 0.78 HPGD (0.78) HPGDCYP2C9CYP2C19MMP2MMP9
SCHEMBL8590717 0.78 CHRNA7 (0.49) HPGDCYP2C9CYP2C19LMNASMN1; SMN2
SCHEMBL11402424 0.77 CYP2C9 (0.51) HPGDCYP2C9CYP2C19MMP2MMP9
SCHEMBL4441106 0.77 CYP2C9 (0.58) HPGDCYP2C9CYP2C19MMP2MMP9
SCHEMBL10937060 0.77 CYP2C9 (0.67) HPGDCYP2C9CYP2C19MMP2MMP9
SCHEMBL5659156 0.75 IFNAR1 (0.62) HPGDCYP2C9CYP2C19TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2061754-A1 BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2009-05-27 EP disclosed
WO-2008115999-A1 BIARYL AND BIHETEROARYL COMPOUNDS USEFUL IN TREATING IRON DISORDERS XENON PHARMACEUTICALS INC. (CA) 2008-09-25 WO disclosed